HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Younes Pilehvar-Soltanahmadi Selected Research

Neoplasms (Cancer)

10/2021Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy.
1/2020Recent advances in electrospun nanofiber-mediated drug delivery strategies for localized cancer chemotherapy.
1/2019Electrochemical Nano-biosensors as Novel Approach for the Detection of Lung Cancer-related MicroRNAs.
11/2018Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells.
9/201817-DMAG-loaded nanofibrous scaffold for effective growth inhibition of lung cancer cells through targeting HSP90 gene expression.
6/2018An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications.
6/2018Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
1/2018Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model.
11/2017Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells.
9/2017Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Younes Pilehvar-Soltanahmadi Research Topics

Disease

15Neoplasms (Cancer)
10/2021 - 08/2016
6Lung Neoplasms (Lung Cancer)
01/2019 - 01/2017
3Breast Neoplasms (Breast Cancer)
12/2018 - 08/2018
3Stomach Neoplasms (Stomach Cancer)
09/2017 - 08/2016
2Wounds and Injuries (Trauma)
01/2021 - 02/2018
2Inflammation (Inflammations)
12/2018 - 09/2018
1Hyperthermia
01/2021
1COVID-19
12/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
04/2018
1Melanoma (Melanoma, Malignant)
01/2018
1Insulin Resistance
12/2017
1Diabetes Mellitus
12/2017
1Colorectal Neoplasms (Colorectal Cancer)
11/2017
1Infections
11/2017
1Carcinoma (Carcinomatosis)
09/2017
1Neoplasm Metastasis (Metastasis)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2016

Drug/Important Bio-Agent (IBA)

6CurcuminIBA
12/2018 - 01/2017
6chrysinIBA
06/2018 - 08/2016
4Metformin (Glucophage)FDA LinkGeneric
01/2021 - 08/2018
4Telomerase (Telomerase Reverse Transcriptase)IBA
09/2018 - 01/2017
4flavoneIBA
06/2018 - 08/2016
3MicroRNAs (MicroRNA)IBA
01/2019 - 08/2016
2PolymersIBA
10/2021 - 01/2017
2Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 12/2018
2Silybin (Lagosa)IBA
12/2018 - 12/2017
2CytokinesIBA
12/2018 - 09/2018
217- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
09/2018 - 06/2018
2AntioxidantsIBA
06/2018 - 02/2018
1LigandsIBA
10/2021
1CyclodextrinsIBA
10/2021
1Small Interfering RNA (siRNA)IBA
10/2021
1Rotaxanes (Rotaxane)IBA
10/2021
1Dendrimers (Dendrons)IBA
10/2021
1CarbohydratesIBA
10/2021
1Plant ExtractsIBA
01/2021
1ferric oxide (iron oxide)IBA
01/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Cyclin D1IBA
12/2018
1Phenformin (Fenformin)IBA
11/2018
1BiguanidesIBA
11/2018
1SilverIBA
11/2018
1polycaprolactoneIBA
09/2018
1Interleukin-6 (Interleukin 6)IBA
09/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2018
1geldanamycinIBA
09/2018
1emu OilIBA
09/2018
1Ethylene Glycol (Monoethylene Glycol)IBA
09/2018
1Proteins (Proteins, Gene)FDA Link
06/2018
1Genetic Markers (Genetic Marker)IBA
04/2018
1PhytochemicalsIBA
02/2018
1methylallyl trisulfide (MATS)IBA
02/2018
1Colloids (Colloid)IBA
02/2018
1Oxygen (Dioxygen)IBA
02/2018
1HydrogelsIBA
02/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2018
1ApelinIBA
12/2017
1AdipokinesIBA
12/2017
1Biological FactorsIBA
11/2017
1EndotoxinsIBA
11/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2017
1PowdersIBA
06/2017
1endostar proteinIBA
10/2016

Therapy/Procedure

13Therapeutics
10/2021 - 01/2017
3Drug Therapy (Chemotherapy)
01/2021 - 11/2017
1Aftercare (After-Treatment)
01/2020
1Artificial Skin
02/2018